Обзорная статья

Peripartum Cardiomyopathy: Review and Practice Guidelines

Leah Johnson-CoyleLeah Johnson-Coyle is a nurse practitioner in cardiac sciences and Alan Sobey is an intensive care physician in the cardiovascular surgery intensive care unit at the Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton, Alberta, Canada. Louise Jensen is a professor in the Faculty of Nursing at the University of Alberta in EdmontonLouise JensenLeah Johnson-Coyle is a nurse practitioner in cardiac sciences and Alan Sobey is an intensive care physician in the cardiovascular surgery intensive care unit at the Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton, Alberta, Canada. Louise Jensen is a professor in the Faculty of Nursing at the University of Alberta in EdmontonAlan SobeyLeah Johnson-Coyle is a nurse practitioner in cardiac sciences and Alan Sobey is an intensive care physician in the cardiovascular surgery intensive care unit at the Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton, Alberta, Canada. Louise Jensen is a professor in the Faculty of Nursing at the University of Alberta in Edmonton

2012en

ABI

Аннотация

Peripartum cardiomyopathy, a type of dilated cardiomyopathy of unknown origin, occurs in previously healthy women in the final month of pregnancy and up to 5 months after delivery. Although the incidence is low-less than 0.1% of pregnancies -morbidity and mortality rates are high at 5% to 32%. The outcome of peripartum cardiomyopathy is also highly variable. For some women, the clinical and echocardiographic status improves and sometimes returns to normal, whereas for others, the disease progresses to severe cardiac failure and even sudden cardiac death. In acute care, treatment may involve the use of intravenous vasodilators, inotropic medications, an intra-aortic balloon pump, ventricular-assist devices, and/or extracorporeal membrane oxygenation. Survivors of peripartum cardiomyopathy often recover from left ventricular dysfunction; however, they may be at risk for recurrence of heart failure and death in subsequent pregnancies. Women with chronic left ventricular dysfunction should be managed according to guidelines of the American College of Cardiology Foundation and the American Heart Association.

Перевод пока недоступен

Идентификаторы

DOI: 10.4037/ajcc2012163

Цитирования и источники

Цитирований: 2Использованных источников: 0

Показатели — AkademScholar